The dissociation between door-to-balloon time improvement and improvements in other acute myocardial infarction care processes and patient outcomes.

BACKGROUND Recent initiatives have focused on reducing door-to-balloon (DTB) times among patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. However, DTB time is only one of several important AMI care processes. It is unclear whether quality efforts targeted to a single process will facilitate concomitant improvement in other quality measures and outcomes. METHODS This study examined 101 hospitals (43 678 patients with AMI) in the Get With the Guidelines program. For each hospital, DTB time improvement from 2005 to 2007 was correlated with changes in composite Centers for Medicare and Medicaid Services/Joint Commission on Accreditation of Healthcare Organizations (CMS/JCAHO) core measure performance and in-hospital mortality. RESULTS Between 2005 and 2007, hospital geometric mean DTB time decreased from 101 to 87 minutes (P < .001). Mean overall hospital composite CMS/JCAHO core measure performance increased from 93.4% to 96.4% (P < .001), and mortality rates were 5.1% and 4.7% (P = .09) in the early and late periods, respectively. Improvement in hospital DTB time, however, was not significantly correlated with changes in composite quality performance (r = -0.06; P = .55) or with in-hospital mortality (r = 0.06; P = .58). After adjustment for patient mix, hospitals with the most improvement in DTB time did not have significantly greater improvements in either CMS/JCAHO measure performance or mortality. CONCLUSIONS Within the Get With the Guidelines program, DTB times decreased significantly over time. However, there was minimal correlation between DTB time improvement and changes in other quality measures or mortality. These results emphasize the important need for comprehensive acute myocardial infarction quality-improvement efforts, rather than focusing on single process measures.

[1]  P. Pronovost,et al.  Public Reporting of Antibiotic Timing in Patients with Pneumonia: Lessons from a Flawed Performance Measure , 2008, Annals of Internal Medicine.

[2]  C. Cannon,et al.  Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: insights from American Heart Association's Get With the Guidelines program. , 2008, American heart journal.

[3]  J. Frieden Hospital Compare Web Site Gives Patients a Voice , 2008 .

[4]  H. Krumholz,et al.  A campaign to improve the timeliness of primary percutaneous coronary intervention: Door-to-Balloon: An Alliance for Quality. , 2008, JACC. Cardiovascular interventions.

[5]  Christopher E. Buller,et al.  2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2008, Journal of the American College of Cardiology.

[6]  B. Gersh,et al.  Regional Systems of Care to Optimize Timeliness of Reperfusion Therapy for ST-Elevation Myocardial Infarction: The Mayo Clinic STEMI Protocol , 2007, Circulation.

[7]  E. Antman,et al.  Development of Systems of Care for ST-Elevation Myocardial Infarction Patients , 2007 .

[8]  Jack A. Meyer,et al.  Hospital Quality Improvement: Strategies and Lessons From U.S. Hospitals , 2007 .

[9]  J. Shiffman HIV/AIDS and the rest of the global health agenda. , 2006, Bulletin of the World Health Organization.

[10]  H. Krumholz,et al.  President's page: GAP-D2B: an alliance for quality. , 2006, Journal of the American College of Cardiology.

[11]  L. Wallentin,et al.  Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. , 2006, JAMA.

[12]  Harlan M Krumholz,et al.  Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. , 2006, Journal of the American College of Cardiology.

[13]  Jane A. Linderbaum,et al.  ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-El , 2006, Circulation.

[14]  R. Collins,et al.  Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.

[15]  Jerod M. Loeb,et al.  Quality of Care in U.S. Hospitals as Reflected by Standardized Measures, 2002-2004 , 2005 .

[16]  Elliott M. Antman,et al.  Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction: Every Minute of Delay Counts , 2004, Circulation.

[17]  Diana B Petitti,et al.  Measuring quality of care and performance from a population health care perspective. , 2003, Annual review of public health.

[18]  Á. Avezum,et al.  Predictors of hospital mortality in the global registry of acute coronary events. , 2003, Archives of internal medicine.

[19]  Klaus Rasmussen,et al.  A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. , 2003, The New England journal of medicine.

[20]  J. Boura,et al.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .

[21]  M. Aschermann,et al.  Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2. , 2003, European heart journal.

[22]  W Klein,et al.  Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). , 2002, European heart journal.

[23]  Robert Parrish,et al.  Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative. , 2002, JAMA.

[24]  R. Sachdeva Measuring the impact of new technology: An outcomes-based approach , 2001, Critical care medicine.

[25]  Gary G. Koch,et al.  Categorical data analysis using the sas® system, 2nd edition , 2000 .

[26]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.